Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lidocaine hydrochloride + isopropyl alcohol + povidone-iodine + methylprednisolone
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Intramuscular, Intraarticular, Intralesional, Parenteral
01
Overview
**DYURAL L KIT** is an unapproved combination injection kit containing methylprednisolone acetate, lidocaine hydrochloride, isopropyl alcohol, and povidone-iodine. Methylprednisolone acetate is a synthetic glucocorticoid that activates the glucocorticoid receptor to suppress inflammatory and immune-mediated signaling. Lidocaine hydrochloride provides local anesthesia through reversible inhibition of voltage-gated sodium channels, while isopropyl alcohol and povidone-iodine are included for antiseptic skin preparation before injection. The kit is intended to support intramuscular, intra-articular, soft-tissue, or intralesional corticosteroid administration for inflammatory, allergic, rheumatologic, dermatologic, and other corticosteroid-responsive disorders.
- Brand names
- DYURAL L KIT
- Other names
- lidocaine hydrochloride + povidone-iodine + isopropyl alcohol + methylprednisolonelidocaine hydrochloride + povidone-iodine + isopropyl alcohol + methylprednisolone acetate
02
Targets
GR (Glucocorticoid receptor)Microbial macromolecules (targeted by free iodine)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on lidocaine hydrochloride + isopropyl alcohol + povidone-iodine + methylprednisolone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lidocaine hydrochloride + isopropyl alcohol + povidone-iodine + methylprednisolone.